|
Mean age
|
63
|
63
|
64
|
|
Female
|
28%
|
27%
|
28%
|
|
Race:
| | | |
|
White
|
86%
|
88%
|
84%
|
|
Black
|
10%
|
10%
|
10%
|
|
Education:
| | | |
|
At least some college
|
90%
|
98%
|
82%†
|
|
Enrolled in a prescription drug plan
|
90%
|
91%
|
89%
|
|
Missed medicine in the last month:
| | | |
|
Less than 5% of time
|
92%
|
90%
|
95%
|
|
6-25% of time
|
4%
|
4%
|
3%
|
|
26-50% of time
|
2%
|
3%
|
2%
|
|
51-75% of time
|
0%
|
0%
|
0%
|
|
76-95% of time
|
1%
|
1%
|
0%
|
|
More than 95% of time
|
1%
|
1%
|
0%
|
|
Have potentially modifiable CHD risk factors:
| | | |
|
Blood pressure > 140/90 (mmHg)
|
36%
|
35%
|
37%
|
|
Total cholesterol/HDL ratio > 4
|
54%
|
53%
|
51%
|
|
Smoker
|
13%
|
14%
|
13%
|
|
Not using aspirin, but eligible for it
|
50%
|
54%
|
47%
|
|
Mean systolic blood pressure (mmHg)
|
136.9
|
136.2
|
137.6
|
|
Mean diastolic blood pressure(mmHg)
|
81.0
|
81.5
|
80.4
|
|
Mean total cholesterol (mg/dL)
|
201.1
|
204.9
|
197.1
|
|
Mean HDL cholesterol (mg/dL)
|
53
|
54.1
|
51.9
|
|
Mean predicted CHD risk over 10 yrs
|
11.3
|
11.2
|
11.4
|
|
# of possible intervention options for CHD risk:‡
| | | |
|
0
|
10%
|
12%
|
8%
|
|
1
|
28%
|
28%
|
27%
|
|
2
|
47%
|
40%
|
54%
|
|
3
|
16%
|
20%
|
11%
|
|
4
|
0%
|
0%
|
0%
|
|
Have self-efficacy to lower at least 1 CHD risk factor
|
98%
|
99%
|
96%
|
|
Are planning best evidence interventions§
|
27%
|
28%
|
25%
|
